Recent Finacing
Recent Raise
Azelon Pharmaceuticals (formerly Zelos Therapeutics) develops novel osteoporosis drug formulations, advancing ZT-034, a teriparatide nasal spray that showed favorable safety/pharmacology, into Phase IIa pharmacodynamic trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors